Author:
Heurling Kerstin,Leuzy Antoine,Zimmer Eduardo R.,Lubberink Mark,Nordberg Agneta
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference102 articles.
1. Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181–92. doi: 10.1002/ana.22248 .
2. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804. doi: 10.1056/NEJMoa1202753 .
3. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol. 2004;55:306–19. doi: 10.1002/ana.20009 .
4. US Food and Drug Administration. FDA approves imaging drug Amyvid: estimates brain amyloid plaque content in patients with cognitive decline. 2012. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm299678.htm . Accessed 24 May 2015.
5. European Medicines Agency. Amyvid: florbetapir (18F). 2013. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002422/human_med_001611.jsp&mid=WC0b01ac058001d124 . Accessed 24 May 2015.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献